EconPapers    
Economics at your fingertips  
 

Flexible graphene-based neurotechnology for high-precision deep brain mapping and neuromodulation in Parkinsonian rats

Nicola Ria, Ahmed Eladly, Eduard Masvidal-Codina, Xavi Illa, Anton Guimerà, Kate Hills, Ramon Garcia-Cortadella, Fikret Taygun Duvan, Samuel M. Flaherty, Michal Prokop, Rob. C. Wykes (), Kostas Kostarelos () and Jose A. Garrido ()
Additional contact information
Nicola Ria: Campus UAB
Ahmed Eladly: Center for Nanotechnology in Medicine & Division of Neuroscience
Eduard Masvidal-Codina: Campus UAB
Xavi Illa: Bellaterra
Anton Guimerà: Bellaterra
Kate Hills: Center for Nanotechnology in Medicine & Division of Neuroscience
Ramon Garcia-Cortadella: Campus UAB
Fikret Taygun Duvan: Campus UAB
Samuel M. Flaherty: Center for Nanotechnology in Medicine & Division of Neuroscience
Michal Prokop: Campus UAB
Rob. C. Wykes: Center for Nanotechnology in Medicine & Division of Neuroscience
Kostas Kostarelos: Campus UAB
Jose A. Garrido: Campus UAB

Nature Communications, 2025, vol. 16, issue 1, 1-16

Abstract: Abstract Deep brain stimulation (DBS) is a neuroelectronic therapy for the treatment of a broad range of neurological disorders, including Parkinson’s disease. Current DBS technologies face important limitations, such as large electrode size, invasiveness, and lack of adaptive therapy based on biomarker monitoring. In this study, we investigate the potential benefits of using nanoporous reduced graphene oxide (rGO) technology in DBS, by implanting a flexible high-density array of rGO microelectrodes (25 µm diameter) in the subthalamic nucleus (STN) of healthy and hemi-parkinsonian rats. We demonstrate that these microelectrodes record action potentials with a high signal-to-noise ratio, allowing the precise localization of the STN and the tracking of multiunit-based Parkinsonian biomarkers. The bidirectional capability to deliver high-density focal stimulation and to record high-fidelity signals unlocks the visualization of local neuromodulation of the multiunit biomarker. These findings demonstrate the potential of bidirectional high-resolution neural interfaces to investigate closed-loop DBS in preclinical models.

Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-025-58156-z Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-58156-z

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-025-58156-z

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-04-02
Handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-58156-z